CRIZOTINIB

9924 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking CRIZOTINIB:

# Side effect Count
0 DEATH 1512
1 DISEASE PROGRESSION 1134
2 NAUSEA 969
3 NEOPLASM PROGRESSION 814
4 DIARRHOEA 703
5 VOMITING 622
6 FATIGUE 484
7 LUNG NEOPLASM MALIGNANT 407
8 VISUAL IMPAIRMENT 371
9 CONSTIPATION 360
See all common reactions for CRIZOTINIB

CRIZOTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SARCOMATOSIS 3 0.2308
1 LEPTOTRICHIA INFECTION 4 0.1290
2 ADENOCARCINOMA METASTATIC 5 0.1190
3 RENAL HYDROCELE 4 0.1143
4 CLEAR CELL SARCOMA OF SOFT TISSUE 2 0.1111
5 NON-SMALL CELL LUNG CANCER 260 0.1101
6 ANAPLASTIC LYMPHOMA KINASE GENE MUTATION 4 0.1053
7 LUNG ADENOCARCINOMA STAGE IV 23 0.1031
8 TRACHEAL CANCER 4 0.1000
9 TRACHEAL INFLAMMATION 7 0.0921
See all enriched reactions for CRIZOTINIB